Atlas Trials

Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis

Clinical trial NCT00809159 · COMPLETED

Trial details

NCT number
NCT00809159
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ankylosing Spondylitis
Start date
2009-03-01
Primary completion
2011-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.